Nearly 400,000 Reddit posts about GLP-1 drugs went through large language models at Penn Engineering. The AI found patient-reported symptoms that clinical trials may have missed: reproductive issues like menstrual irregularities and temperature complaints including chills and hot flashes. About 4% of users reported reproductive symptoms. Fatigue ranked second most common despite rarely showing up in trial reporting thresholds. The study is published in Nature Health.
The researchers, led by Sharath Chandra Guntuku, Lyle Ungar, and doctoral student Neil Sehgal, call their approach 'computational social listening.' While other Penn research focuses on how AI influences human logic, this team maps patient symptoms. They used GPT and Gemini to map informal patient language to standardized medical terms at a scale manual review couldn't match. Known side effects like nausea showed up too, which validated the approach. 'Some of the side effects we found, like nausea, are well known, and that shows that the method is picking up a real signal,' Guntuku said.
The caveats matter though. There's no control group. Hot flashes and menstrual irregularities are common in middle-aged women, the exact demographic taking these weight-loss drugs. Without comparing to similar women not on GLP-1s, separating drug effects from normal occurrence is hard. The researchers don't claim causation. 'We can't say that GLP-1s are actually causing these symptoms,' Sehgal noted. They see it as signal detection worth clinical follow-up.
Funding came from NIH grants (National Institute on Aging and National Cancer Institute), not pharma. No conflicts of interest were disclosed. That matters because so much GLP-1 research comes from Novo Nordisk or Eli Lilly. This is LLMs turning messy patient forums into structured pharmacovigilance data, fast. 'Clinical trials are the gold standard, but by design, they are slow,' Guntuku said. 'This can move much faster, and that speed matters when a drug goes from niche to mainstream almost overnight.'